IFNL4polymorphism effects on outcome of simeprevir, peginterferon, and ribavirin therapy for older patients with genotype 1 chronic hepatitis C-Reference-Cited by-同舟云学术

IFNL4polymorphism effects on outcome of simeprevir, peginterferon, and ribavirin therapy for older patients with genotype 1 chronic hepatitis C

Published:2016-04-21 Issue:3 Volume:47 Page:E5-E13
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Mori Nami¹,Imamura Michio²,Kawakami Yoshiiku²,Nagaoki Yuko²,Kawaoka Tomokazu²,Tsuge Masataka²,Hiramatsu Akira²,Hayes C. Nelson²,Aikata Hiroshi²,Miki Daiki²³,Ochi Hidenori²³,Honda Yohji¹,Takaki Shintaro¹,Tsuji Keiji¹,Chayama Kazuaki²³,

Affiliation:

1. Department of Gastroenterology/Liver Center; Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital; Hiroshima Japan

2. Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical and Health Science; Hiroshima University; Hiroshima Japan

3. Laboratory for Digestive Diseases, SNP Research Center; The Institute of Physical and Chemical Research (RIKEN); Hiroshima Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12715/fullpdf

Reference31 articles.

1. Risk factors for hepatocellular carcinoma among patients with chronic liver disease;Tsukuma;N Engl J Med,1993

2. Prognosis of chronic hepatitis C: results of a large, prospective cohort study;Niederau;Hepatology,1998

3. Global epidemiology of hepatitis C virus infection;Shepard;Lancet Infect Dis,2005

4. Long-term mortality after transfusion-associated non-A, non-B hepatitis;Seeff;N Engl J Med,1992

5. Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3;Liakina;J Viral Hepat,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient‐specific genetic factors predict treatment failure in sofosbuvir‐treated patients with chronic hepatitis C;Liver International;2022-02-21

2. Impact of IFNL4 -∆G genotype on sustained virologic response in hepatitis C genotype 1 patients treated with direct-acting antivirals;Diagnostic Microbiology and Infectious Disease;2018-09

3. Correlation of interferon-lambda 4 ss469415590 with the hepatitis C virus treatment response and its comparison with interleukin 28b polymorphisms in predicting a sustained virological response: a meta-analysis;International Journal of Infectious Diseases;2016-12

4. Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C;PLOS ONE;2016-11-22